Common Contracts

2 similar Licensing Agreement contracts

Licensing agreement for Captisol-enabled intravenous formulation of clopidogrel
Licensing Agreement • January 28th, 2022 • New Jersey

Ligand has licensed exclusive worldwide rights to The Medicines Company for Ligand’s Captisol-enabled intravenous formulation of clopidogrel.

AutoNDA by SimpleDocs
Licensing agreement for Captisol-enabled intravenous formulation of clopidogrel
Licensing Agreement • January 28th, 2022 • New Jersey

Ligand has licensed exclusive worldwide rights to The Medicines Company for Ligand’s Captisol-enabled intravenous formulation of clopidogrel.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!